• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压中巨噬细胞的变化:聚焦于高原肺动脉高压

Changes in Macrophages in Pulmonary Hypertension: A Focus on High-altitude Pulmonary Hypertension.

作者信息

Ma Wende, Ma Yumei, Bai Yuting, Su Xiaoling

机构信息

Qinghai University, Xining, Qinghai, China; Compact Medical Service Community in Menyuan County, Menyuan, Qinghai, China.

Department of Digestive, Qinghai Provincial People's Hospital, Xining, Qinghai, China.

出版信息

Anatol J Cardiol. 2025 Mar 10;29(5):210-21. doi: 10.14744/AnatolJCardiol.2025.5013.

DOI:10.14744/AnatolJCardiol.2025.5013
PMID:40062372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12053306/
Abstract

High-altitude pulmonary hypertension (HAPH) is a condition characterized by elevated pulmonary arterial pressure exceeding normal physiological values, resulting from a combination of high-altitude low-pressure, hypoxic environments, genetic susceptibility, immune dysfunction, and neurogenic disturbances. This condition predominantly manifests as right heart failure, severely impacting quality of life and life expectancy. Macrophages, as one of the most prevalent innate immune cells, have been increasingly recognized for their crucial role in the pathogenesis of HAPH. The low-pressure and hypoxic environment, along with other etiological factors, lead to metabolic abnormalities in tissue cells and the microenvironment. This results in increased secretion of chemokines, cytokines, and growth factors in the microenvironment, which promote the proliferation of tissue-resident macrophages and the differentiation of monocytes recruited from the blood into macrophages. This exacerbates the inflammatory cascade, further promoting cell proliferation, tissue repair, and inhibition of apoptosis. These processes contribute to the migration and proliferation of pulmonary arterial smooth muscle cells, endothelial cells, and fibroblasts, leading to vascular remodeling and ultimately the development of pulmonary arterial hypertension. This review examines the role of macrophage-mediated immune responses in high-altitude pulmonary arterial hypertension, with a focus on hypoxia as a key feature.

摘要

高原性肺动脉高压(HAPH)是一种以肺动脉压力升高超过正常生理值为特征的病症,其由高原低压、缺氧环境、遗传易感性、免疫功能障碍和神经源性紊乱共同作用所致。这种病症主要表现为右心衰竭,严重影响生活质量和预期寿命。巨噬细胞作为最普遍的固有免疫细胞之一,其在HAPH发病机制中的关键作用日益受到认可。低压和缺氧环境以及其他病因导致组织细胞和微环境出现代谢异常。这致使微环境中趋化因子、细胞因子和生长因子的分泌增加,进而促进组织驻留巨噬细胞的增殖以及从血液招募而来的单核细胞分化为巨噬细胞。这加剧了炎症级联反应,进一步促进细胞增殖、组织修复并抑制细胞凋亡。这些过程促使肺动脉平滑肌细胞、内皮细胞和成纤维细胞迁移和增殖,导致血管重塑并最终引发肺动脉高压。本综述探讨巨噬细胞介导的免疫反应在高原性肺动脉高压中的作用,重点关注缺氧这一关键特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9270/12053306/5d969b083b49/ajc-29-5-210_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9270/12053306/d1ce46ed459b/ajc-29-5-210_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9270/12053306/e3a8835c6ec9/ajc-29-5-210_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9270/12053306/5d969b083b49/ajc-29-5-210_f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9270/12053306/d1ce46ed459b/ajc-29-5-210_f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9270/12053306/e3a8835c6ec9/ajc-29-5-210_f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9270/12053306/5d969b083b49/ajc-29-5-210_f003.jpg

相似文献

1
Changes in Macrophages in Pulmonary Hypertension: A Focus on High-altitude Pulmonary Hypertension.肺动脉高压中巨噬细胞的变化:聚焦于高原肺动脉高压
Anatol J Cardiol. 2025 Mar 10;29(5):210-21. doi: 10.14744/AnatolJCardiol.2025.5013.
2
Protective effects of the Terminalia bellirica tannin-induced Nrf2/HO-1 signaling pathway in rats with high-altitude pulmonary hypertension.没食子酸棓单宁诱导 Nrf2/HO-1 信号通路对高原性肺动脉高压大鼠的保护作用。
BMC Complement Med Ther. 2023 May 6;23(1):150. doi: 10.1186/s12906-023-03981-2.
3
Research Progress of Inflammatory Factors in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension at High Altitude.高原地区慢性阻塞性肺疾病合并肺动脉高压炎症因子的研究进展。
Altern Ther Health Med. 2023 Nov;29(8):689-693.
4
High-altitude pulmonary hypertension: a comprehensive review of mechanisms and management.高原性肺动脉高压:机制与管理的全面综述
Clin Exp Med. 2025 Mar 10;25(1):79. doi: 10.1007/s10238-025-01577-3.
5
Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure.低气压低氧暴露引起的肺动脉高压和水肿中的炎症反应。
Int J Mol Sci. 2022 Oct 21;23(20):12656. doi: 10.3390/ijms232012656.
6
Asymmetric Dimethylarginine at Sea Level Is a Predictive Marker of Hypoxic Pulmonary Arterial Hypertension at High Altitude.海平面的不对称二甲基精氨酸是高海拔地区缺氧性肺动脉高压的预测标志物。
Front Physiol. 2019 May 27;10:651. doi: 10.3389/fphys.2019.00651. eCollection 2019.
7
NLRC3 deficiency promotes hypoxia-induced pulmonary hypertension development via IKK/NF-κB p65/HIF-1α pathway.NLRC3 缺乏通过 IKK/NF-κB p65/HIF-1α 通路促进低氧诱导的肺动脉高压发展。
Exp Cell Res. 2023 Oct 15;431(2):113755. doi: 10.1016/j.yexcr.2023.113755. Epub 2023 Aug 14.
8
Halofuginone prevents inflammation and proliferation of high-altitude pulmonary hypertension by inhibiting the TGF-β1/Smad signaling pathway.常山酮通过抑制TGF-β1/Smad信号通路预防高原肺动脉高压的炎症和增殖。
Sci Rep. 2025 Jan 29;15(1):3619. doi: 10.1038/s41598-025-88258-z.
9
Immunoregulatory Macrophages Modify Local Pulmonary Immunity and Ameliorate Hypoxic Pulmonary Hypertension.免疫调节巨噬细胞调节局部肺部免疫并减轻低氧性肺动脉高压。
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):e288-e303. doi: 10.1161/ATVBAHA.124.321264. Epub 2024 Oct 10.
10
Intermittent short-duration reoxygenation protects against simulated high altitude-induced pulmonary hypertension in rats.间歇性短时间复氧可预防大鼠模拟高原性肺动脉高压。
FASEB J. 2021 Feb;35(2):e21212. doi: 10.1096/fj.202000533RR. Epub 2020 Nov 23.

引用本文的文献

1
Integrative proteomics and metabolomics reveal important pathways and potential biomarkers in high-altitude pulmonary hypertension.整合蛋白质组学和代谢组学揭示了高原肺动脉高压中的重要通路和潜在生物标志物。
Sci Rep. 2025 Jul 11;15(1):24999. doi: 10.1038/s41598-025-09477-y.

本文引用的文献

1
Immunoregulatory Macrophages Modify Local Pulmonary Immunity and Ameliorate Hypoxic Pulmonary Hypertension.免疫调节巨噬细胞调节局部肺部免疫并减轻低氧性肺动脉高压。
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):e288-e303. doi: 10.1161/ATVBAHA.124.321264. Epub 2024 Oct 10.
2
The Seventh World Symposium on Pulmonary Hypertension: our journey to Barcelona.第七届世界肺动脉高压研讨会:我们前往巴塞罗那的旅程。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01222-2024. Print 2024 Oct.
3
Tibetan mesenchymal stem cell-derived exosomes alleviate pulmonary vascular remodeling in hypoxic pulmonary hypertension rats.
西藏间充质干细胞来源的外泌体可减轻低氧性肺动脉高压大鼠的肺血管重构。
Stem Cells. 2024 Aug 1;42(8):720-735. doi: 10.1093/stmcls/sxae032.
4
The role of monocyte/macrophage chemokines in pathogenesis of osteoarthritis: A review.单核细胞/巨噬细胞趋化因子在骨关节炎发病机制中的作用:综述。
Int J Immunogenet. 2024 Jun;51(3):130-142. doi: 10.1111/iji.12664. Epub 2024 Mar 10.
5
Macrophage-derived inflammation promotes pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension mice.巨噬细胞衍生的炎症促进缺氧诱导的肺动脉高压小鼠的肺血管重塑。
Immunol Lett. 2023 Nov;263:113-122. doi: 10.1016/j.imlet.2023.10.005. Epub 2023 Oct 22.
6
In the Search for Biomarkers of Pulmonary Arterial Hypertension, Are Cytokines IL-2, IL-4, IL-6, IL-10, and IFN-Gamma the Right Indicators to Use?在寻找肺动脉高压的生物标志物时,细胞因子 IL-2、IL-4、IL-6、IL-10 和 IFN-γ 是否是合适的指标?
Int J Mol Sci. 2023 Sep 5;24(18):13694. doi: 10.3390/ijms241813694.
7
TGF-β signaling in health and disease.转化生长因子-β 信号在健康和疾病中的作用。
Cell. 2023 Sep 14;186(19):4007-4037. doi: 10.1016/j.cell.2023.07.036.
8
Neutrophil extracellular traps boost laser-induced mouse choroidal neovascularization through the activation of the choroidal endothelial cell TLR4/HIF-1α pathway.中性粒细胞胞外诱捕网通过激活脉络膜内皮细胞 TLR4/HIF-1α 通路促进激光诱导的小鼠脉络膜新生血管形成。
FEBS J. 2023 Nov;290(22):5395-5410. doi: 10.1111/febs.16928. Epub 2023 Sep 4.
9
TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats.肿瘤坏死因子-α(TNF-α)和白细胞介素-8(IL-8)水平与大鼠低压低氧性肺动脉高压及肺血管重塑呈正相关。
Open Life Sci. 2023 Jul 27;18(1):20220650. doi: 10.1515/biol-2022-0650. eCollection 2023.
10
Physiology and diseases of tissue-resident macrophages.组织驻留巨噬细胞的生理学和疾病。
Nature. 2023 Jun;618(7966):698-707. doi: 10.1038/s41586-023-06002-x. Epub 2023 Jun 21.